Business Standard

Dr Reddy's appoints Erez Israeli as COO and head of global generics biz

Israeli will join Dr Reddy's on April 2, 2018. He will report to its co-chairman and CEO G V Prasad

reddy, dr reddy's
Premium

Dr Reddy's laboratory

BS Reporter Hyderabad
Dr Reddy's Laboratories Limited on Thursday announced a change in the senior leadership team. The company has appointed former president and CEO of Enzymotec, Erez Israeli, as the chief operating officer and global head of generics and PSAI (pharmaceutical services and active ingredients).

He will replace Abhijit Mukherjee, who is retiring on March 31, 2018 after a 15-year stint at Dr Reddy's. For the first time, the company is bringing in a senior management hand from outside India though a couple of senior people from global pharma industry have been currently serving on the board as independent, non-wholetime directors.  

Israeli's entry comes

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 29 2018 | 4:25 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com